The role of fluvoxamine in the treatment of endotoxin‐induced acute heart injury
British Journal of Pharmacology · 2026
DOI: 10.1111/bph.70453 ↗At a glance
Journal article in British Journal of Pharmacology, 2026. Written by Ilter Ilhan and 5 co-authors. Institution: Department of Medical Biochemistry, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey. Major MEDLINE topics: Fluvoxamine, Heart Injuries, Anti-Inflammatory Agents, Selective Serotonin Reuptake Inhibitors. 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: Scientific Research Projects Coordination Unit of Suleyman Demirel University.
Abstract (original language)
Background and Purpose Cardiovascular diseases are among the most common health problems worldwide. Inflammation plays a critical role in the pathogenesis of various heart diseases. Lipopolysaccharides (LPS) trigger inflammatory mechanisms, leading to an inflammatory response. Fluvoxamine (FLV) is a selective serotonin reuptake inhibitor with anti‐inflammatory and antioxidative properties. This study investigated the potential protective effects of FLV on sepsis‐induced cardiac inflammation and injury. Experimental Approach Thirty‐two female Wistar Albino rats were divided into four groups: control, LPS (5 mg·kg −1 intraperitoneally), LPS + FLV, and FLV (50 mg·kg −1 ·day −1 orally for 3 days). Thirty minutes after the final FLV administration, LPS was administered, and animals were killed 6 h later. Cardiac tissues were evaluated by histopathological analysis, immunohistochemical assessment of caspase‐3, TNF‐α, interleukin‐1 beta (IL‐1β), interleukin‐6 receptor (IL‐6R), IL‐10, and NF‐κB; biochemical determination of total oxidant status (TOS), total antioxidant status (TAS), and oxidative stress index (OSI); and gene expression analysis by real‐time quantitative polymerase chain reaction (RT‐qPCR) of sirtuin‐1 (SIRT‐1), nuclear factor erythroid 2–related factor 2 (NRF‐2), peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha (PGC‐1α), and p53. Key Results LPS administration significantly increased TOS, OSI, caspase‐3, TNF‐α, IL‐1β, IL‐6R, NF‐κB, and p53, while decreasing IL‐10, SIRT‐1, NRF‐2, and PGC‐1α, accompanied by marked inflammatory and structural cardiac damage. FLV treatment markedly reversed these alterations, attenuating inflammation, oxidative stress, and apoptosis. Conclusion and Implications These findings suggest that FLV may confer cardioprotection against LPS‐induced inflammatory and apoptotic cardiac injury, potentially through modulation of IL‐6R/NF‐κB‐mediated inflammatory signalling and the SIRT‐1–NRF‐2–PGC‐1α axis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medical Biochemistry, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
- Department of Medical Pharmacology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
- Department of Medical Genetics, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
- Department of Medical Pharmacology, Faculty of Medicine, İstanbul Yeni Yüzyıl University, Istanbul, Turkey.
- Department of Pathology, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.
ORCID profiles: Ilter Ilhan, Halil Aşcı, Muhammet Yusuf Tepebasi, Nursel Hasseyid, Melih Arlıoğlu, Özlem Özmen
Funding
- Scientific Research Projects Coordination Unit of Suleyman Demirel University
Cite
APA
Ilhan, I., Aşcı, H., Tepebasi, M. Y., Hasseyid, N., Arlıoğlu, M., & Özmen, Ö. (2026). The role of fluvoxamine in the treatment of endotoxin‐induced acute heart injury. British Journal of Pharmacology. https://doi.org/10.1111/bph.70453
Vancouver
Ilhan I, Aşcı H, Tepebasi MY, Hasseyid N, Arlıoğlu M, Özmen Ö. The role of fluvoxamine in the treatment of endotoxin‐induced acute heart injury. British Journal of Pharmacology. 2026. doi:10.1111/bph.70453
BibTeX
@article{Ilhan2026,
author = {Ilhan, Ilter and Aşcı, Halil and Tepebasi, Muhammet Yusuf and Hasseyid, Nursel and Arlıoğlu, Melih and Özmen, Özlem},
title = {The role of fluvoxamine in the treatment of endotoxin‐induced acute heart injury},
journal = {British Journal of Pharmacology},
year = {2026},
doi = {10.1111/bph.70453}
}
EUVIMED